ПИРРОЛИЛТИАЗОЛЫ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ОБРАТНЫХ АГОНИСТОВ РЕЦЕПТОРА СВ 1

摘要

The present invention relates to compounds of formula (I) wherein R¹, R², R³, R⁴, R⁵, R⁶ and R⁷ are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB1 receptors.